Prescribed a GLP-1 medication but struggling to get it covered?
GLP-1 medications are now prescribed to millions of Americans for type 2 diabetes and weight management. Getting the prescription is often the easy part. Getting the medication at a price you can afford, and keeping it month after month, can be much harder.
Bridging the Gap explains the access process in plain language, so you can ask better questions and work more effectively with your prescriber, pharmacy, and insurance plan.
A detailed guide to the Medicare GLP-1 Bridge
On July 1, 2026, Medicare launched the Medicare GLP-1 Bridge, a temporary program that covers certain GLP-1 medications for weight management at a $50 monthly copay for eligible people with Medicare drug coverage. Three chapters walk you through who qualifies, how the prior authorization process works, what the copay does and does not count toward, and how to plan for the program’s scheduled end on December 31, 2027.
Help for every type of coverage
Whether you have Medicare, insurance through an employer, Medicaid, or no insurance at all, this guide explains the options that apply to you, including:
- How your diagnosis shapes your coverage
- Prior authorization, step therapy, and formulary exceptions
- How manufacturer savings cards work, including caps and expiration dates
- Patient assistance programs and self-pay options
- Medicaid coverage and the BALANCE Model
- How to appeal a denial
- How to recognize unsafe compounded and counterfeit products
Practical tools you can use right away
The guide includes checklists, comparison tables, questions to ask your prescriber and insurance plan, an appeal documentation checklist, and a one-page personal access plan.
About this guide
This guide is published by Apex Tome for educational and informational purposes. It is designed to help readers better understand GLP-1 medication access and support informed conversations with qualified healthcare professionals. It is not intended to replace professional medical advice, diagnosis, or treatment, and it does not recommend any specific medication or dose.
